Alcohol septal ablation in hypertrophic obstructive cardiomyopathy: The need for a registry

Circulation

Volumn 102, Issue 6, 2000, Pages 600-601

  Spencer III, William H ^a   Roberts, Robert ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Ablation; Cardiomyopathy; Editorials; Genetics

Indexed keywords

ALCOHOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DISOPYRAMIDE; VERAPAMIL;

AUTOSOMAL DOMINANT INHERITANCE; COMPLETE HEART BLOCK; EDITORIAL; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MYOMECTOMY; MYOTOMY; PRIORITY JOURNAL;

EID: 0034622607     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.6.600     Document Type: Editorial

References (23)

1. Hypertrophic cardiomyopathy: Interrelations of clinical manifestations, pathophysiology, and therapy: Part 1
2. Hypertrophic cardiomyopathy: Interrelations of clinical manifestations, pathophysiology, and therapy: Part 2
3. Hypertrophic cardiomyopathy: Clinical spectrum and treatment
4. The management of hypertrophic cardiomyopathy
5. Perspectives on the role of new treatment strategies in hypertrophic cardiomyopathy
6. Long-term results of dual chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy: Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy
7. Effects of dual chamber pacing in hypertrophic obstructive cardiomyopathy
8. Dual-chamber pacing for hypertrophic cardiomyopathy: A randomized, double-blind, crossover trial
9. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy: A randomized double-blind, crossover study (M-PATHY)
10. Operative treatment in hypertrophic subaortic stenosis: Techniques and the results of pre and postoperative assessments in 83 patients
11. Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy
12. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy
13. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: Outcome in the first series of patients
14. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and 3-month follow-up in 25 patients
15. Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy
16. Non-surgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: One year follow-up
17. Therapeutic options in patient with obstructive hypertrophic cardiomyopathy and severe drug-refractory symptoms
18. Role of alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy
19. Expression of a mutation causing hypertrophic cardiomyopathy in adult feline cardiomyocytes disrupts sarcomere assembly in adult feline cardiac myocytes
20. Recent advances in the molecular genetics of hypertrophic cardiomyopathy
21. The myocardium in hyperfunction, hypertrophy and heart failure
22. Purkinje-muscle reentry as a mechanism of polymorphic ventricular arrhythmias in a 3-dimensional model of the ventricles
23. Mechanisms underlying spontaneous and induced ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy